1. Home
  2. YHC vs CING Comparison

YHC vs CING Comparison

Compare YHC & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LQR House Inc.

YHC

LQR House Inc.

HOLD

Current Price

$0.91

Market Cap

8.7M

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$4.06

Market Cap

26.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YHC
CING
Founded
2021
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
26.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
YHC
CING
Price
$0.91
$4.06
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$31.33
AVG Volume (30 Days)
325.5K
127.9K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,103,341.00
N/A
Revenue This Year
$69.97
N/A
Revenue Next Year
$403.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$3.20
52 Week High
$98.00
$6.01

Technical Indicators

Market Signals
Indicator
YHC
CING
Relative Strength Index (RSI) 53.70 53.63
Support Level $0.82 $3.81
Resistance Level $0.91 $4.30
Average True Range (ATR) 0.06 0.26
MACD 0.00 0.00
Stochastic Oscillator 60.39 36.99

Price Performance

Historical Comparison
YHC
CING

About YHC LQR House Inc.

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: